Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis
Authors
Keywords
-
Journal
World Psychiatry
Volume 15, Issue 2, Pages 166-174
Publisher
Wiley
Online
2016-06-06
DOI
10.1002/wps.20309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prevention of diabetes and cardiovascular disease in people with schizophrenia
- (2015) R. I. G. Holt ACTA PSYCHIATRICA SCANDINAVICA
- The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis
- (2015) B. Stubbs et al. ACTA PSYCHIATRICA SCANDINAVICA
- TYPE 2 DIABETES IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A META-ANALYSIS OF PREVALENCE ESTIMATES AND PREDICTORS
- (2015) Davy Vancampfort et al. DEPRESSION AND ANXIETY
- Prevalence and Predictors of Type 2 Diabetes Mellitus in People With Bipolar Disorder
- (2015) Davy Vancampfort et al. JOURNAL OF CLINICAL PSYCHIATRY
- Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial
- (2015) P. Gardner-Sood et al. PSYCHOLOGICAL MEDICINE
- Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
- (2015) Christoph U. Correll et al. World Psychiatry
- Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study
- (2015) Christoph U. Correll et al. World Psychiatry
- Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
- (2015) Davy Vancampfort et al. World Psychiatry
- Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
- (2015) MARC DE HERT et al. World Psychiatry
- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
- (2015) MARC DE HERT et al. World Psychiatry
- Pharmacologic and Behavioral Interventions to Improve Cardiovascular Risk Factors in Adults With Serious Mental Illness
- (2014) Jennifer M. Gierisch et al. JOURNAL OF CLINICAL PSYCHIATRY
- Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort
- (2014) Ulrich Reininghaus et al. SCHIZOPHRENIA BULLETIN
- Markers of inflammation in schizophrenia: association vs. causation
- (2014) Peter Manu et al. World Psychiatry
- Risks of all-cause and suicide mortality in mental disorders: a meta-review
- (2014) Edward Chesney et al. World Psychiatry
- Diabetes, physical activity participation and exercise capacity in patients with schizophrenia
- (2013) Davy Vancampfort et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Antidepressant use and glycemic control
- (2013) Ramin Mojtabai PSYCHOPHARMACOLOGY
- A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls
- (2013) Davy Vancampfort et al. World Psychiatry
- The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers
- (2013) D. Lawrence et al. BMJ-British Medical Journal
- Avoidable mortality in people with schizophrenia or bipolar disorder in England
- (2012) U. Hoang et al. ACTA PSYCHIATRICA SCANDINAVICA
- Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis
- (2012) Alex J. Mitchell et al. BRITISH JOURNAL OF PSYCHIATRY
- Glucose Metabolism and Antidepressant Medication
- (2012) Johannes M. Hennings et al. CURRENT PHARMACEUTICAL DESIGN
- Risk Factors Associated With Metabolic Syndrome in Bipolar and Schizophrenia Subjects Treated With Antipsychotics
- (2012) Vicki L. Ellingrod et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Christopher J L Murray et al. LANCET
- Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression
- (2012) F Lamers et al. MOLECULAR PSYCHIATRY
- Trends in Use of Second-Generation Antipsychotics for Treatment of Bipolar Disorder in the United States, 1998–2009
- (2012) Jessica Pillarella et al. PSYCHIATRIC SERVICES
- Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia
- (2012) Davy Vancampfort et al. PSYCHIATRY RESEARCH
- Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation
- (2011) M. De Hert et al. BRITISH JOURNAL OF PSYCHIATRY
- International Organization of Physical Therapy in Mental Health consensus on physical activity within multidisciplinary rehabilitation programmes for minimising cardio-metabolic risk in patients with schizophrenia
- (2011) Davy Vancampfort et al. DISABILITY AND REHABILITATION
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London
- (2011) Chin-Kuo Chang et al. PLoS One
- Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices
- (2011) A. J. Mitchell et al. PSYCHOLOGICAL MEDICINE
- Treatment with antipsychotics and the risk of diabetes in clinical practice
- (2010) Lars Vedel Kessing et al. BRITISH JOURNAL OF PSYCHIATRY
- Review: Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis
- (2010) Alex J Mitchell et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients
- (2010) Jimmi Nielsen et al. NEUROPSYCHOPHARMACOLOGY
- Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies
- (2009) Alex J. Mitchell et al. BRITISH JOURNAL OF PSYCHIATRY
- Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
- (2009) M. De Hert et al. EUROPEAN PSYCHIATRY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Antipsychotics and Diabetes: An Age-Related Association
- (2008) Ariel Hammerman et al. ANNALS OF PHARMACOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search